Labajo, Erbien G.
HRN: 23-60-66 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/17/2023
09/23/2023
IVT
490mg
Q8
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes